Hepatitis C Virus, Nucleocapsid (core), Recombinant, aa2-192 (HCV) (Biotin)
Catalog No : USB-208978
531.05€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Hepatitis C Virus, Nucleocapsid (core), Recombinant, aa2-192 (HCV) (Biotin) | ||
---|---|---|---|
Catalog No | USB-208978 | ||
Supplier’s Catalog No | 208978 | ||
Supplier | US Biologicals | ||
Source antigen | Recombinant, E. coli | ||
Reactivity | |||
Cross reactivity | |||
Applications | |||
Molecular weight | 22 |
Storage | -20°C | ||
---|---|---|---|
Other names | |||
Grade | Highly Purified | ||
Purity | Highly Purified (~95%) | ||
Form | Supplied as a liquid in 25mM Tris-Hcl, pH 8, 1mM EDTA, 1.5M urea. Labeled with Biotin. | ||
Reactivity life | 12 months | ||
Note | For reserch purpose only | ||
Purity | Highly Purified (~95%) | ||
Description | HCV is a small 50nm, enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae. HCV has a high rate of replication with ~one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes (1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). Source: Recombinant protein corresponding to the HCV NS3 immunodominant regions, aa2-192, fused to beta-Galactosidase at N-terminus, expressed in E. coli. Molecular Weight: ~22kD Specificity: Immunoreactive with sera of HCV-infected individuals. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
© 2020 Imugex All Rights Reserved